Le Journal des Entreprises highlights EncapX®
11 June 2026
Le Journal des Entreprises (June 2026) features EncapX® under the headline “Biotech One révolutionne l’encapsulation des substances actives”. The article looks at the encapsulation of fragile molecules such as RNA, peptides, anticancer compounds and gene therapies. It highlights better stability and shelf life, and a scalable alternative to microfluidics.
Related news
Biotech One raises €1M to industrialise its clean technologies
€1M from Région Sud Investissement and CAAP Création to deploy EncapX® and Extract-X® at industrial scale.
8 April 2026
Fabien Balme interviewed by Planète Ingénieur
Why encapsulating fragile molecules such as RNA is an industrial challenge, and how EncapX® goes from a patented process to a ready-to-use machine.
27 March 2026
Biotech One pitches EncapX® to France BioLead members
An exclusive member session on 6 November, on bridging R&D formulation and industrial bioproduction for liposome and LNP manufacturing.
5 November 2026